Homocystinuria
An inherited disorder of methionine metabolism, most often due to cystathionine beta-synthase (CBS) deficiency, leading to elevated homocysteine with effects on the eyes, bones, blood vessels, and nervous system.
- Often CBS Gene-Related
- Detected by Newborn or Targeted Screening
- Managed with Diet, Vitamins & Medication
- Better Outcomes with Early Treatment
- Most Common Cause
- CBS Gene Deficiency
- Inheritance Pattern
- Autosomal Recessive
- Typical Onset
- Childhood to Early Adulthood
- Core Management
- Diet, B-Vitamins, Betaine
- Specialist Support
- Metabolic Care Access
Condition Overview
Homocystinuria is an inherited disorder of amino acid metabolism, most commonly caused by deficiency of the enzyme cystathionine beta-synthase (CBS), which is needed to break down homocysteine. When this pathway is impaired, homocysteine accumulates in the blood and is excreted in the urine, contributing to effects on the eye lens, skeleton, blood vessels, and nervous system.
Some forms of homocystinuria respond to high-dose vitamin B6 (pyridoxine), while others require dietary methionine restriction, betaine therapy, or other targeted approaches. Early diagnosis and consistent treatment can substantially reduce the risk of serious complications such as lens dislocation or abnormal blood clotting.
Types and Biochemical Classification
Homocystinuria can result from different underlying enzyme defects, which influences treatment approach and response.
Symptoms and Signs
Symptoms of homocystinuria often develop gradually over childhood and adolescence, affecting multiple body systems.
Causes and Risk Factors
Homocystinuria is caused by inherited defects in enzymes responsible for processing the amino acid homocysteine.
Diagnosis and Investigations
Diagnosis combines biochemical testing for elevated homocysteine with genetic confirmation and assessment of eye, skeletal, and vascular involvement.
Severity Classification
Homocystinuria severity is generally categorized by treatment responsiveness and degree of organ involvement rather than a formal staging system.
Standard Management
Treatment of homocystinuria aims to lower homocysteine levels through vitamin therapy, dietary management, and medication, tailored to the individual's underlying defect and treatment response.
Specialized & Emerging Management Approaches
Beyond standard vitamin and dietary therapy, specialized centers offer additional support for complex or treatment-resistant cases, and research continues into new approaches.
Nutritional Therapy
Specialized Low-Methionine Medical Formula
Tailored medical foods support adequate nutrition while restricting methionine intake in non-pyridoxine-responsive cases.
Pharmacologic Therapy
Betaine (Trimethylglycine) Therapy
Used to lower homocysteine through an alternate remethylation pathway, particularly in non-responsive or partially responsive patients.
Ophthalmologic Care
Specialist Lens Dislocation Management
Surgical and monitoring approaches for lens dislocation in collaboration with ophthalmology specialists experienced in metabolic eye disease.
Emerging Research
Enzyme Replacement & Gene-Based Research
Early-stage research into enzyme replacement and gene-based strategies for CBS deficiency is ongoing, though not yet part of routine clinical care.
Relevant Laboratory Markers
Biochemical markers are central to diagnosing homocystinuria and tracking response to treatment over time.
When to Seek a Specialist Second Opinion
Because homocystinuria management can be complex, a specialist second opinion is valuable when biochemical control is difficult to achieve or complications arise.
Research and Clinical Studies
Outlook and Long-Term Management
With early diagnosis and consistent treatment, many individuals with homocystinuria can reduce their risk of serious eye, skeletal, and vascular complications and lead active lives.
Supportive Care and Daily Living
Living with homocystinuria involves coordinated care across nutrition, vision health, and vascular risk monitoring.
How CancerFax Helps You Explore Treatment Options
CancerFax can help you get specialist review of biochemical and genetic test results related to Homocystinuria and connect you with experienced metabolic disease specialists.
Get a free case reviewFrequently Asked Questions
It is an inherited disorder, most often due to CBS gene deficiency, that causes elevated homocysteine levels with effects on the eyes, bones, blood vessels, and nervous system.
Vision changes, a tall and thin body build, or developmental concerns are often the first noticeable signs, though presentation varies widely between individuals.
Diagnosis involves measuring plasma homocysteine and amino acid levels, followed by genetic testing to confirm the underlying defect.
Treatment depends on the underlying defect and may include high-dose vitamin B6, dietary methionine restriction, and betaine therapy.
There is no cure, but consistent treatment can substantially lower homocysteine levels and reduce the risk of complications.
Elevated homocysteine affects connective tissue that supports the eye's lens, making dislocation a characteristic finding in this condition.
No, responsiveness varies by the specific underlying gene variant; some individuals require dietary and additional medical therapy instead.
Yes, elevated homocysteine increases the risk of abnormal blood clotting, which is why vascular risk monitoring is an important part of care.
Yes, siblings and other close relatives of someone diagnosed with homocystinuria are often advised to undergo testing or counseling.
Yes. CancerFax can help you submit biochemical and genetic reports for specialist review, request a second opinion on diagnosis or management, and connect with metabolic disease specialists internationally.
Get Expert Guidance on Homocystinuria
Send your biochemical and genetic reports for specialist review and connect with metabolic disease experts to support your care plan.